论文部分内容阅读
1型糖尿病(T1DM)是儿科常见的内分泌疾病之一,其发病率呈逐年上升趋势。近些年来,由于一些新的治疗方法的问世,如胰岛素类似物的出现,持续皮下胰岛素注射应用的推广,儿童T1DM的治疗各地区所采用的方法均不尽相同。为了使儿童T1DM胰岛素治疗更加规范化,现参照国际儿童及青少年糖尿病协会(ISPAD)颁布的2009年统一指南,对儿童T1DM胰岛素治疗进展进行讲述。
Type 1 diabetes (T1DM) is one of the common endocrine diseases in pediatrics, and its incidence has been increasing year by year. In recent years, due to the advent of some new treatments, such as the emergence of insulin analogues and the continuous promotion of subcutaneous insulin injection, the methods adopted by children in various regions of T1DM are different. To further standardize the treatment of children with T1DM insulin, the progress of T1DM insulin therapy in children is described with reference to the 2009 uniform guidelines promulgated by the International Association of Children and Adolescents and Diabetes (ISPAD).